Jeffrey E. Russel

Array ( [id] => 6825686 [patent_doc_number] => 20030236308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Compositions of cyclooxygenase-2 selective inhibitors and acetaminophen for treatment and prevention of inflammation, inflammation-mediated disorders and pain' [patent_app_type] => new [patent_app_number] => 10/246846 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15704 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236308.pdf [firstpage_image] =>[orig_patent_app_number] => 10246846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652171 [patent_doc_number] => 20030105154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Statin-carboxyalkylether combinations' [patent_app_type] => new [patent_app_number] => 10/245005 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105154.pdf [firstpage_image] =>[orig_patent_app_number] => 10245005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774682 [patent_doc_number] => 20030018020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Detection and treatment of duplex polynucleotide damage' [patent_app_type] => new [patent_app_number] => 10/235433 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7750 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018020.pdf [firstpage_image] =>[orig_patent_app_number] => 10235433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774693 [patent_doc_number] => 20030018031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Formulations of 5HT agonists' [patent_app_type] => new [patent_app_number] => 10/227990 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3374 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018031.pdf [firstpage_image] =>[orig_patent_app_number] => 10227990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136755 [patent_doc_number] => 20040044220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin' [patent_app_type] => new [patent_app_number] => 10/227158 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044220.pdf [firstpage_image] =>[orig_patent_app_number] => 10227158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861727 [patent_doc_number] => 20030092735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome' [patent_app_type] => new [patent_app_number] => 10/222060 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5233 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092735.pdf [firstpage_image] =>[orig_patent_app_number] => 10222060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669457 [patent_doc_number] => 20030114441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Heterocyclic anti-epileptogenic agents and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/222141 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22054 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114441.pdf [firstpage_image] =>[orig_patent_app_number] => 10222141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756429 [patent_doc_number] => 20030004206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Carvedilol-lipophilic solutions' [patent_app_type] => new [patent_app_number] => 10/218785 [patent_app_country] => US [patent_app_date] => 2002-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3392 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004206.pdf [firstpage_image] =>[orig_patent_app_number] => 10218785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843698 [patent_doc_number] => 20030149045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Therapeutic compounds' [patent_app_type] => new [patent_app_number] => 10/211045 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 37418 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149045.pdf [firstpage_image] =>[orig_patent_app_number] => 10211045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674825 [patent_doc_number] => 20030060428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome' [patent_app_type] => new [patent_app_number] => 10/210787 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6970 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060428.pdf [firstpage_image] =>[orig_patent_app_number] => 10210787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792621 [patent_doc_number] => 20030087965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines' [patent_app_type] => new [patent_app_number] => 10/207420 [patent_app_country] => US [patent_app_date] => 2002-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1899 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087965.pdf [firstpage_image] =>[orig_patent_app_number] => 10207420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852147 [patent_doc_number] => 20030144350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Fat accumulation-modulation compounds' [patent_app_type] => new [patent_app_number] => 10/201588 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15742 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144350.pdf [firstpage_image] =>[orig_patent_app_number] => 10201588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6520840 [patent_doc_number] => 20020192318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Anticholesterolemic edible oil' [patent_app_type] => new [patent_app_number] => 10/196777 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6410 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192318.pdf [firstpage_image] =>[orig_patent_app_number] => 10196777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736132 [patent_doc_number] => 20030013767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Method of treating weight loss using creatine' [patent_app_type] => new [patent_app_number] => 10/193853 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3200 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013767.pdf [firstpage_image] =>[orig_patent_app_number] => 10193853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809557 [patent_doc_number] => 20030199496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use' [patent_app_type] => new [patent_app_number] => 10/186402 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9733 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199496.pdf [firstpage_image] =>[orig_patent_app_number] => 10186402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745761 [patent_doc_number] => 20030022944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors' [patent_app_type] => new [patent_app_number] => 10/175643 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46670 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022944.pdf [firstpage_image] =>[orig_patent_app_number] => 10175643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756352 [patent_doc_number] => 20030004129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Formulations of adenosine a1 agonists' [patent_app_type] => new [patent_app_number] => 10/168242 [patent_app_country] => US [patent_app_date] => 2002-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6020 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004129.pdf [firstpage_image] =>[orig_patent_app_number] => 10168242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861759 [patent_doc_number] => 20030092767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Combination therapy for the treatment of inflammatory and respiratory diseases' [patent_app_type] => new [patent_app_number] => 10/149365 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092767.pdf [firstpage_image] =>[orig_patent_app_number] => 10149365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736040 [patent_doc_number] => 20030013675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/154561 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35926 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013675.pdf [firstpage_image] =>[orig_patent_app_number] => 10154561 [rel_patent_id] =>[rel_patent_doc_number] =>)